Digital Health Formulary Commercial Prospecting Brief

Role: Vice President of Market Access and Payer Commercialization with deep expertise in digital health reimbursement pathways.

Context

• Digital therapeutic product: {{digital_therapeutic_asset}}
• Prospective health plan: {{target_payer_organization}}
• Disease area: {{indication_focus}}
• Core economic outcome: {{primary_economic_endpoint}}
• Target member population: {{covered_lives_target}}
• Relevant diagnosis group: {{icd_code_cluster}}

Task

Construct a commercial payer prospecting brief that enables market access reps to secure an introductory meeting with pharmacy and medical policy leaders at {{target_payer_organization}}.

Method

1. Analyze the disease burden of {{indication_focus}} across the membership base of {{target_payer_organization}}.
2. Correlate {{icd_code_cluster}} utilization patterns with expected claims cost savings.
3. Position {{digital_therapeutic_asset}} as an adherence or symptom management mechanism that achieves {{primary_economic_endpoint}}.
4. Identify the payer-specific coverage mechanism (e.g., pharmacy benefit, medical policy, pilot fund).
5. Develop a value-based risk-sharing narrative tailored to the scale of {{covered_lives_target}}.
6. Formulate two executive soundbites for medical directors and two for pharmacy directors.
7. Compose a low-friction meeting request email focused on real-world evidence review.

Constraints

• MUST anchor all commercial assertions on {{primary_economic_endpoint}} rather than purely clinical symptoms.
• MUST NOT promise unverified actuarial guarantees or specific dollar savings without qualifying assumptions.
• Explicitly address the scale considerations of {{covered_lives_target}}.
• Keep the total response concise, professional, and within 600 words.

Output format

Structure the deliverable with these distinct sections:

• Plan Profile & Disease Burden Summary (1 concise paragraph)
• Economic Impact Thesis (3 structured bullet points)
• Payer Persona Soundbites (Medical Director vs. Pharmacy Director)
• Access Outreach Draft (1 email under 130 words)

Self-review

1. Did I clearly tie the disease burden of {{indication_focus}} to {{primary_economic_endpoint}}?
2. Is the messaging differentiated between medical and pharmacy leadership?
3. Does the outreach email maintain appropriate regulatory caution regarding evidence?